Peanut Oral Immunotherapy (OIT)
Peanut oral immunotherapy (OIT) with peanut allergen powder-dnfp (Palforzia®) is an FDA-approved treatment for children ages 4 to 17 years that can help reduce the risk and severity of allergic reactions to peanuts, including anaphylaxis.
Information for Nurse Practitioners and Physician Assistants
When patients have frequent symptoms such as wheezing, coughing, shortness of breath, rashes or hives, an allergist can help provide long-term solutions.
ACAAI Roundtable on Atopic Dermatitis and Food Allergy
In February 2022, American College of Allergy, Asthma and Immunology convened experts in atopic dermatitis and food allergy to examine the issue of racial disparities affecting people with these conditions.
Clinical Trial Resources
Involvement in clinical trials provides the opportunity to further medical research and improve patient outcomes.
